Novartis Vaccines and Diagnostics Services AG

Novartis Vaccines and Diagnostics Services AG, headquartered in Switzerland (CH), currently does not report specific carbon emissions data, as no emissions figures are available. The company is a current subsidiary of Novartis AG, which cascades its climate commitments and initiatives down to its subsidiaries.

Novartis AG has set ambitious climate targets, including commitments to the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP). These initiatives aim to significantly reduce greenhouse gas emissions across all scopes, although specific reduction targets for Novartis Vaccines and Diagnostics Services AG have not been detailed.

As part of its corporate family, Novartis Vaccines and Diagnostics Services AG aligns with Novartis AG's broader sustainability goals, which include transitioning to renewable energy sources and enhancing energy efficiency. The company is also involved in initiatives such as RE100 and the Race to Zero campaign, which further demonstrate its commitment to climate action.

In summary, while specific emissions data for Novartis Vaccines and Diagnostics Services AG is not available, the company is integrated into Novartis AG's comprehensive climate strategy, which focuses on significant reductions in carbon emissions and sustainable practices.